In 2011 there have been roughly 15 stocks to return gains of more than 100% that began the year between the price range of $10 and $20. A large reason is the volatility within the market and a high number of momentum stocks that have traded much lower during the last five months. Below I have included several stocks between $10 and $20 that I believe will trend higher throughout 2012, in fact I believe that each of the below stocks present the possibility more than double in 2012.
Throughout the last year I've suggested buying auto stocks to anyone who would listen, and Ford (F) is one of the two that I believe will double in 2012. I have attempted to find a logical reason and explain why Ford has traded with a loss of 35% during the last year but I've been unable to find a decent reason. The company's posted great sales numbers during the last year and is now selling units at its best rate since cash-for-clunkers. I believe that as the company's focus on innovation and fuel efficiency continues to evolve its stock will trend higher. And now that the company's implemented a dividend I expect more long-term investors that won't overreact to the volatility in the market which will ultimately allow the company's fundamental progress to reflect as large gains in its stock.
As I said, I'm a big believer that the auto industry will lead the market in gains for 2012; and I expect other companies that benefit from a strong auto market to trade higher as well. Goodyear Tire & Rubber Company (GT) manufactures the tires, and other rubber related parts, that are used on several best selling vehicles. GT had actually been trending higher until late July when the market's selloff resulted in new 52 week lows. The company is growing revenue at an impressive rate which includes a 22% gain year-over-year during its most recent quarter and an 18% gain during the last 12 months compared to 2010. However, the company's ability to improve margins is what I find impressive: the company posted a loss of $216 million in 2010 but is now trading with net income of $126 million.
The company's made vast improvements over the last year and is now trading with a profit for the first time since 2007. The stock currently trades 34x earnings; however the forward P/E of this stock is just 5.77 which show analysts expect the company's impressive growth to continue at its current rate. And I expect GT to post large gains in 2012 with growing fundamentals in an industry that is remarkably undervalued.
My next two stocks that I expect or believe could double in 2012 are basic materials stocks. Basic materials have been beaten down over the last six months and trail only the financial sector in six month loss: with a 15.30% loss. The largest reason has been the price performance of commodities such as silver, gold, and other metal futures. These stocks have traded lower during the last six months regardless of fundamental gains as some expect metals to trade lower in 2012. However, I anticipate a strong year for metals and I expect for the following companies to post such large fundamental gains that it results in 100% gains in 2012, if commodities can stabilize.
Stillwater Mining Company (SWC) is perhaps the most controversial stock on this list. The company's the only miner of platinum & palladium in the U.S. and its largest customers; General Motors (NYSE:GM) and Ford Motor Company (F) are two companies that I expect to continue growing and selling more vehicles resulting in more metal consumption. If you look at the company's earnings and price performance alone you would believe this stock is undervalued however it's not the company's 77% revenue growth or its nearly 600% earnings growth year-over-year that has investors concerned.
The recent decline of the stock is a result of the company's decision to enter gold and copper mining and the price it paid for the peregrine mines, which was a large premium. At this time it's difficult to say for sure if the company paid too much or what reasoning the company used when purchasing the mines. However, I do anticipate the success of companies such as GM and F having an impact on this stock and I believe investors oversold in fear that the company made a bad decision with the peregrine mines. The stock trades at a 131% premium to the market's volatility and has a history of wild price swings in a short period of time. Therefore if the company can prove to investors that the peregrine mines can produce profitability and that sales of its other metals are improving as well then I expect this stock to make a nice recover and shift from pessimism to optimism among investors, which will be key in determining the future trend of this stock.
Endeavour Silver Corporation (EXK) is probably my favorite steel stock within the market and I anticipate strong gains for the stock in 2012. The company has several catalysts for gains in 2012 including growth in earnings, cash-flow, production, reserve resources, discoveries, and the potential for several acquisition which is a part of its strategic plan. The company has no debt with rising sales and falling costs; and is currently posting record earnings.
During the last 12 months the company's increased revenue by 61% compared to 2010; and has posted net income of $33.69 million compared to a loss of $20.74 million in the year prior with much lower costs and better margins. The revenue growth is due to a rise in production of nearly 850% over the last 6 years and strong demand. The company has two high grade silver/gold operations in Mexico and I believe that although commodities have declined as of late most will recover in 2012 and continue its historic trend towards higher gains. Most silver/gold mining companies have significant downside risks associated with an investment but with EXK, which is trading at just 13.46x future earnings, I see few downside risks and significant upside potential for a company growing at this remarkable level.
My favorite biotech company within the market is Spectrum Pharmaceuticals (SPPI) which has returned 136% year-to-date on unprecedented growth. Despite the stock's large returns in 2011 I believe it's significantly undervalued with a market cap of under $850 million. In a previous article I identified the advantages to this company and compared its valuation to speculative biotech companies and other companies with similar levels of growth. And what I explained is that there are several biotech companies without an FDA approved drug trading with a higher valuation. In addition, companies such as Questcor Pharmaceuticals (QCOR) which is one of my favorite stocks, trades with similar fundamentals and slower growth yet is valued at more that 3x SPPI.
The fundamental growth of this company is unmatched to any other biotech company with two fast growing FDA approved drugs and two candidates that will likely be awarded approval in 2012. The only questions surrounding the company are a potential generic for the company's fastest growing drug Fusilev and a bioscan requirement for its other drug, Zevalin, which increases the cost and hinders growth. Both questions have been answered with Fusilev's patent protected until 2019 and the bioscan requirement has been lifted by the FDA which should result in faster growth for Zevalin. Therefore I'm expecting a much larger valuation in 2012 and for SPPI to trade much higher than 19x earnings as the company returns a remarkable level of growth.
During the year prior to July 13 Basic Energy Services (BAS) returned more than 330% but has since lost nearly 50% of its value. BAS is one of the fastest growing energy companies in the market; however its stock performance was negatively affected with the drop in commodities and the overwhelming fear within the market during the months of August and September. Yet despite fear and its current valuation the company's fundamentals continue to grow with revenue increasing 51% during the last 12 months compared to 2010; and net income of $22.68 million during the last 12 months compared to a loss of $43.56 million in the year prior.
The company's showing no signs of slowing down and I believe is presenting a perfect opportunity for investors to take advantage of a company that is growing but has fallen because of profit taking. And I don't believe there is anyway possible that this stock trades at only 8x earnings, next year's forward P/E, during 2012 with such incredible growth. Therefore I wouldn't be surprised if BAS is one of the best performing stocks of 2012 with gains of more than 100%.
Disclosure: I am long EXK, SPPI, BAS, F.